Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205
Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical trial of CYTO-205 for the treatment of ... Read More
Our Food to invest $200m in Telangana in micro food processing units
Our Food Pvt Ltd, a portfolio company of 3Lines' Fund I, said that it will invest more than $200 million in the southern Indian state ... Read More
Sobi begins avatrombopag phase 3 trial in immune thrombocytopenia in pediatrics
Swedish Orphan Biovitrum (Sobi) said that the first patient has been dosed with Doptelet (avatrombopag) in a phase 3 trial for the treatment of immune ... Read More
JD Sports to acquire 60% stake in Marketing Investment Group
British sportswear retailer JD Sports Fashion has signed a conditional agreement for acquiring a 60% stake in Marketing Investment Group (MIG) for an undisclosed price. ... Read More
Auto parts maker Holley to go public in $1.5bn merger deal with Empower
US auto parts maker Holley has agreed to merge with Empower, a publicly-traded special purpose acquisition company (SPAC), in a deal worth around $1.55 billion. ... Read More
Instacart bags $265m in new funding for online grocery delivery service
Online grocery delivery company Instacart has raised $265 million in a new financing round to more than double its valuation to $39 billion. The new ... Read More
Dabur India launches Dabur Vatika Select shampoo range
Dabur India has expanded its Vatika products range by launching 'Dabur Vatika Select' range of shampoos. Dabur Vatika Select has been initially rolled out on ... Read More
Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab
Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 billion, to add ... Read More
Adani Ports to acquire stake in Gangavaram Port for $270m
The Adani Ports and Special Economic Zones (Adani Ports or APSEZ) will acquire the 31.5% stake owned by Windy Lakeside Investment in the Gangavaram Port ... Read More
Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn
Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based pharma company, for about $1.55 billion. The ... Read More